-Member Login

Forgot your USERNAME OR PASSWORD?

Job Postings

Let's Stay Connected

Find us on the popular social networks

Facebook Twitter LinkedIn Flicker

U.S. House of Representatives Approves 21st Century Cures; Bill Heads to Senate

Go back To Policy Updates

 

The House on November 30 approved the 21st Century Cures Act , 392-26, amended by a Manager’s Amendment submitted by House Energy and Commerce Chair Fred Upton (R-Mich.). While the Manager’s Amendment modifies slightly the allocation of funding in the NIH Innovation Account on an annual basis, it maintains the overall level of funding in the Account at a total of $4.796 billion between FYs 2017 and 2026. For the Precision Medicine Initiative, the Amendment provides $1.455 billion between FYs 2017 and 2026; for BRAIN, $1.511 billion between FYs 2017 and 2026; for cancer research, $1.8 billion between FYs 2017 and 2023; and for clinical research to advance regenerative medicine using adult stem cells, the Amendment provides $30 million between FYs 2017 and 2020.

Committee materials, bill text, list of supporting organizations, and the Manager’s Amendment and other materials are available at the following links:


Last updated: December 1, 2016 

Hot Links 

EB2017 

Join ASPET 

What is Pharmacology? Video 

PharmTalk Blog